Equity Based Compensation

6 Months Ended

Jun. 30, 2022

Share-based Payment Arrangement [Abstract]

Equity Based Compensation

Equity Based Compensation

Equity compensation expense was $17 million and $24 million in the first six months of 2022 and 2021, respectively. In the first quarter of 2022, the Company granted 258,327 stock appreciation rights at $106.53 weighted average exercise price per share, 78,687 performance contingent shares and 219,553 restricted stock units to employees. Additionally, non-employee directors were granted a total of 17,937 shares of common stock. As of June 30, 2022, 1,705,128 share awards at a weighted average strike price per share of $105.83 were vested and exercisable, with a remaining weighted average exercise period of 4.3 years. As of June 30, 2022, the total compensation cost of non-vested awards not yet recognized in the condensed consolidated financial statements was $42 million. It is estimated that these costs will vest over a weighted average period of 0.8 years.